BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 21119930)

  • 1. Variability in melanoma metalloproteinase expression profiling.
    Giricz O; Lauer JL; Fields GB
    J Biomol Tech; 2010 Dec; 21(4):194-204. PubMed ID: 21119930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
    Milner JM; Rowan AD; Cawston TE; Young DA
    Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential gene expression profiling of metalloproteinases and their inhibitors: a comparison between bovine intervertebral disc nucleus pulposus cells and articular chondrocytes.
    Cui Y; Yu J; Urban JP; Young DA
    Spine (Phila Pa 1976); 2010 May; 35(11):1101-8. PubMed ID: 20473119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes.
    Flannery CR; Little CB; Caterson B; Hughes CE
    Matrix Biol; 1999 Jun; 18(3):225-37. PubMed ID: 10429942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.
    Stokes A; Joutsa J; Ala-Aho R; Pitchers M; Pennington CJ; Martin C; Premachandra DJ; Okada Y; Peltonen J; Grénman R; James HA; Edwards DR; Kähäri VM
    Clin Cancer Res; 2010 Apr; 16(7):2022-35. PubMed ID: 20305301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive gene expression profiling and functional analysis of matrix metalloproteinases and TIMPs, and identification of ADAM-10 gene expression, in a corneal model of epithelial resurfacing.
    Gordon GM; Austin JS; Sklar AL; Feuer WJ; LaGier AJ; Fini ME
    J Cell Physiol; 2011 Jun; 226(6):1461-70. PubMed ID: 20625997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic expression of A disintegrin and metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases.
    Schwettmann L; Wehmeier M; Jokovic D; Aleksandrova K; Brand K; Manns MP; Lichtinghagen R; Bahr MJ
    J Hepatol; 2008 Aug; 49(2):243-50. PubMed ID: 18490073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers.
    Hida Y; Hamada J
    Anticancer Agents Med Chem; 2012 Sep; 12(7):744-52. PubMed ID: 22292754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAM and ADAMTS gene expression in native and wound healing human lens epithelial cells.
    Hodgkinson LM; Wang L; Duncan G; Edwards DR; Wormstone IM
    Mol Vis; 2010 Dec; 16():2765-76. PubMed ID: 21197111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes.
    Agapova OA; Ricard CS; Salvador-Silva M; Hernandez MR
    Glia; 2001 Mar; 33(3):205-16. PubMed ID: 11241738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of proteinases in the human preovulatory follicle of the menstrual cycle by human chorionic gonadotropin.
    Rosewell KL; Al-Alem L; Zakerkish F; McCord L; Akin JW; Chaffin CL; Brännström M; Curry TE
    Fertil Steril; 2015 Mar; 103(3):826-33. PubMed ID: 25516084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of hyaluronic acid on bone in osteoarthritis: matrix metalloproteinases, aggrecanases, and RANKL expression are partially prevented by hyaluronic acid in interleukin 1-stimulated osteoblasts.
    Mladenovic Z; Saurel AS; Berenbaum F; Jacques C
    J Rheumatol; 2014 May; 41(5):945-54. PubMed ID: 24737908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.
    Zhong S; Khalil RA
    Biochem Pharmacol; 2019 Jun; 164():188-204. PubMed ID: 30905657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
    Figueira RC; Gomes LR; Neto JS; Silva FC; Silva ID; Sogayar MC
    BMC Cancer; 2009 Jan; 9():20. PubMed ID: 19144199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of ADAMs and their inhibitors in sputum from patients with asthma.
    Paulissen G; Rocks N; Quesada-Calvo F; Gosset P; Foidart JM; Noel A; Louis R; Cataldo DD
    Mol Med; 2006; 12(7-8):171-9. PubMed ID: 17088949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disintegrin-like and cysteine-rich domains of ADAM-9 mediate interactions between melanoma cells and fibroblasts.
    Zigrino P; Nischt R; Mauch C
    J Biol Chem; 2011 Feb; 286(8):6801-7. PubMed ID: 21135106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metalloproteinases in melanoma.
    Moro N; Mauch C; Zigrino P
    Eur J Cell Biol; 2014; 93(1-2):23-9. PubMed ID: 24530009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The developmental and acute phases of insulin-induced laminitis involve minimal metalloproteinase activity.
    de Laat MA; Kyaw-Tanner MT; Nourian AR; McGowan CM; Sillence MN; Pollitt CC
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):275-81. PubMed ID: 21333362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.